Financiere des Professionnels - Fonds d'investissement inc.
Position in EXEL — Exelixis, Inc.
CIK 1996846
MONTREAL, A8
Position in EXEL
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,857,611
+$270,338 QoQ
Shares Held
34,141
-7.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#271
of 751 holders
Holding Since
Jun 2025
5 quarters on record
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Financiere des Professionnels - Fonds d'investissement inc. holds $26,230,262 across 23 Biotechnology names. EXEL ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,141 | $3,052,745 | |
| 2 | ARGX |
Argenx SE
|
3,257 | $3,021,746 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,556 | $2,263,101 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,171 | $1,977,245 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
34,141 | $1,857,611 | |
| 6 | RPRX |
Royalty Pharma plc
|
32,413 | $1,817,396 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
9,241 | $1,730,654 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
20,467 | $1,171,121 |
All Filings in EXEL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,857,611 | 34,141 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $1,587,273 | 37,008 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $1,263,005 | 28,816 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $800,270 | 19,377 | Shares | Defined | 2025-10-21 | |
| 2025-06-30 | $910,472 | 20,655 | Shares | Defined | 2025-07-11 | |
| No filing history on record for this holder in this stock. | ||||||